Bristol Myers Squibb and Pfizer launch direct-to-patient Eliquis program
Go back to Bristol Myers Squibb and Pfizer launch direct-to-patient Eliquis program| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 58.13 +2.32 (4.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.81 | 52 Week High | $77.12 | |||
| Open | $56.65 | 52 Week Low | $49.03 | |||
| Day High | $58.14 | P/E | 37.75 | |||
| Day Low | $56.41 | EPS | $1.54 | |||
| Volume | 10,003,974 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.32 +0.44 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.88 | 52 Week High | $37.39 | |||
| Open | $24.15 | 52 Week Low | $28.25 | |||
| Day High | $24.57 | P/E | 14.74 | |||
| Day Low | $24.13 | EPS | $1.65 | |||
| Volume | 53,203,200 | |||||
